Metabolic syndrome in a workplace: Prevalence, co-morbidities, and economic impact

Metabolic Syndrome and Related Disorders

Volumn 7, Issue 5, 2009, Pages 459-468

  Schultz, Alyssa B ^a   Edington, Dee W ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEALTH CARE COST; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; WORKPLACE;

ABSENTEEISM; ADULT; COMORBIDITY; DRUG COSTS; EFFICIENCY; FEMALE; HEALTH CARE COSTS; HEALTHY PEOPLE PROGRAMS; HUMANS; INDUSTRY; INSURANCE, DISABILITY; LINEAR MODELS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDWESTERN UNITED STATES; OCCUPATIONAL HEALTH; PREVALENCE; WORKPLACE;

EID: 70350340989     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2009.0008     Document Type: Article

References (47)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
2. Alberti KG, Zimmet PZ. Defi nition, diagnosis and classifi cation of diabetes mellitus and its complications. Part 1. Diagnosis and classifi cation of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
3. National Institutes of Health. Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. Bethesda, MDP: National Institutes of Health, National Heart, Lung and Blood Institute; 2001 (NIH publ. no. 01-3670)
4. Aberti KG, Zimmet P, Shaw J. Metabolic synbdrome-a new world-wide defi nition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientifi c Statement. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
6. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed defi nitions. Diabetes Care 2003;26:575-581.
7. Koehler C, Ott P, Benke I, Hanefeld M. Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF defi nitions in a German population with type 2 diabetes: The Diabetes in German (DIG) study. Horm Metab Res 2007;39:632-635.
8. Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF defi nitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev 2007;23:127-134.
9. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: Prevalence and associated risk factor fi ndings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 2002;163:427-436.
10. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA 2002;287:356-359.
11. Godefroi R, Klementowicz P, Pepler C, Lewis B, McDonough K, Goldberg RJ. Metabolic syndrome in a screened worksite sample: Prevalence and predictors. Cardiology 2005;103:131-136.
12. Braunstein A, Li Y, Hirschland D, McDonald T, Edington DW. Internal associations among health-risk factors and risk prevalence. Am J Health Behav 2001;25:407-417.
13. Alexander CM, Landsman PB, Teutch SM, et al. NCEP-defi ned metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-1214.
14. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States Adults. Circulation 2004;110:1245-1250.
15. Hu G, Qiao Q, Tuomilehto J, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164:1066-1076.
16. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle- aged men. JAMA 2002;288:2709-2716.
17. Wilson PW, Kannel WB, Silbershatz H et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999;259:1104-1109.
18. Grundy S, Hansen B, Smith S, et al. Clinical management of metabolic syndrome: Report of the American Heart Association/ National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientifi c issues related to management. Circulation 2004;109:551-556. (Pubitemid 38168522)
19. Ninomiya JK, L'Italien G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004;109:42-46.
20. Costa LA, Canani LH, Lisboa HR et al. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med 2004;21:252-255.
21. Lakksonen DE, Lakka HM, Niskanen LK et al. Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested defi nitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156:1070-1077.
22. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the "Metabolic Syndrome" and incidence of type 2 diabetes. Diabetes 2002;51:3120-3127.
23. Burton WN, Chen CY, Schultz AB, Conti DJ, Pransky G, Edington DW. Worker productivity loss associated with arthritis. Dis Manag 2006;9:131-143.
24. Burton WN, Chen CY, Conti DJ, Schultz AB, Edington DW. The association between health risk change and presenteeism change. J Occup Environ Med 2006;48:252-263.
25. Burton WN, McCalister KT, Chen CY, Edington DW. The association of health status, worksite fi tness center participation, and two measures of productivity. J Occup Environ Med 2005;47:343-351.
26. Burton WN, Chen CY, Conti DJ, Schultz AB, Pransky G, Edington DW. The association of health risks with on-the-job productivity. J Occup Environ Med 2005;47:769-777.
27. Burton WN, Chen CY, Conti DJ, Pransky G, Edington DW. Caregiving for ill dependents and its association with employee health risks and productivity. J Occup Environ Med 2004;46:1048-1056.
28. US Department of Health and Human Services, Offi ce of Public Health and Science, Offi ce of Disease Prevention and Health Promotion. Guide to Clinical Preventive Services. Washington, DC: Government Printing Offi ce; 2006.
29. Cyr A, Hagen S. Measurement and quantifi cation of presenteeism. J Occup Environ Med 2007;49:1299-1300.
30. Mattke S, Balakrishnan A, Bergamo G, Newberry SJ. A review of methods to measure health-related productivity loss. Am J Managed Care 2007;13:211-217.
31. Koopmanschap M, Burdorf A, Jacob K, Meerding WJ, Brouwer W, Severens H. Measuring productivity changes in economic evaluation: Setting the research agenda. Pharmacoeconomics 2005;23:47-54.
32. Burton WN, Chen CY, Schultz AB, Edington DW. The prevalence of metabolic syndrome in an employed population and the impact on health and productivity. J Occup Environ Med 2008;50:1139-1148.
33. Oberlinner C, Humpert PM, Nawroth PP, Zober A, Morcos M. Metabolic syndrome in a large chemical company: Prevalence in a screened worksite sample. Acta Diabetol 2007;45:31-35.
34. Behavioral Risk Factor Surveillance System Maps. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. Available at: http://apps.nccd.cdc.gov/gisbrfss/default.aspx/. Accessed October, 2008.
35. McMichael AJ. Standardized mortality ratios and the "healthy worker effect": Scratching beneath the surface. J Occup Med 1976;18:165-168.
36. Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jockel KH. Impact of 4 different defi nitions used for the assessment of the prevalence of the metabolic syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 2007;6:22.
37. Ford ES. Prevalence of the metabolic syndrome defi ned by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-2749.
38. Loevinger BL, Muller D, Alonso C, Coe CL. Metabolic syndrome in women with chronic pain. Metabolism 2007;56:87-93.
39. Balci K, Utku U. Carpal tunnel syndrome and metabolic syndrome. Acta Neurol Scand 2007;116:113-117.
40. Werner RA, Albers JW, Franzblau A, Armstrong TJ. The relationship between body mass index and the diagnosis of carpal tunnel syndrome. Muscle Nerve 1994;7:632-636. (Pubitemid 24157387)
41. Werner RA, Franzblau A, Albers JW, Armstrong TJ. Infl uence of body mass index and work activity on the prevalence of median mononeuropathy at the wrist. Occup Environ Med 1997;54:268-271.
42. Dessein PH, Joffe BI, Stanwix A, Botha AS, Moomal Z. The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in infl ammatory arthritis. J Rheumatol 2002;29:462-466.
43. Hurt-Camejo E, Paredes S, Masana L, Camejo G, Sartipy P, Rosengren B, Pedreno J, Vallve JC, Benito P, Wiklund O. Elevated levels of small, low-density lipoprotein with high affi nity for arterial matrix components in patients with rheumatoid arthritis. Arthritis Rheum 2001;44:2761-2767.
44. Jakovljevic M, Crncevic Z, Ljubicic D, Babic D, Topic R, Saric M. Mental disorders and metabolic syndrome: A fatamorgana or warning reality? Psychiatr Danub 2007;19:76-86.
45. Taylor V, MacQueen G. Associations between bipolar disorder and metabolic syndrome: A review. J Clin Psychiatry 2006;67:1034-1041.
46. Lakka TA, Laaksonen DE, Lakka HM, Mannikko N, Niskanene LK, Rauramaa R, Salonen JT. Sedentary lifestyle, poor cardiorespiratory fi tness, and the metabolic syndrome. Med Sci Sports Exerc 2003;35:1279-1286.
47. Chan DC, Watts GF, Barrett PHR, Burke V. Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. QJM 2003;96:441-447.